Retinal Degeneration D012162

Diseases [C] » Eye Diseases [C11] » Eye Diseases, Hereditary » Retinal Degeneration

Diseases [C] » Eye Diseases [C11] » Retinal Diseases » Retinal Degeneration

Description

A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)   MeSH

Hierarchy View

Subtype Terms (4)

Macular Degeneration
227 drugs (81 approved, 146 experimental)

Retinal Drusen
9 drugs (5 approved, 4 experimental)

Retinal Dystrophies
6 drugs (3 approved, 3 experimental)

Retinoschisis
5 drugs (4 approved, 1 experimental)


Phase 4 Indicated Drugs (2)

Phase 3 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 3 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.